In addition, we observed a highly significant increased number of transitional memory T cells upon lenalidomide treatment (mean: 50.34% versus 57.88% for the CD4 + T cells and 13.09% versus 25.31% for the CD8 + T cells).
← all excerpts
Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation.
1
—
—